Company intelligence / Profile preview
HAC Pharma
Caen, France
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
HAC Pharma is a French independent pharmaceutical company with a focus on launching and marketing mature and innovative, high therapeutic value drugs across Europe, particularly in areas with reduced treatment alternatives. The company is fully commercial stage, distributing in-licensed and acquired products such as bexarotene (TARGRETIN) and estriol (TROPHICREME), and recently out-licensed melatonin (Mellozzan) for ADHD-related sleep disorders in children. Clinical data on proprietary development is limited; activity centers on commercialization and distribution.
- Therapeutic areas
- ImmunologyEndocrinologyRare DiseasesGastroenterologyHematologyCardiovascularNeurologyWomen's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Beyond the preview
Go deeper on HAC Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HAC Pharma.